Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateTimeSourceHeadlineSymbolCompany
07/05/202106:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
06/05/202121:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
29/04/202121:30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2021 Earnings and Company UpdatesNASDAQ:NTLAIntellia Therapeutics Inc
29/04/202109:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
29/04/202106:54Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NTLAIntellia Therapeutics Inc
29/04/202106:39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
28/04/202106:35GlobeNewswire Inc.Intellia Therapeutics Announces Presentations at the 24th American Society of Gene and Cell Therapy Annual MeetingNASDAQ:NTLAIntellia Therapeutics Inc
14/04/202106:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
12/04/202121:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
12/04/202121:30GlobeNewswire Inc.Intellia Therapeutics Names Georgia Keresty, Ph.D., M.P.H., to Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
07/04/202108:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
30/03/202122:30GlobeNewswire Inc.Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR ...NASDAQ:NTLAIntellia Therapeutics Inc
25/03/202122:30GlobeNewswire Inc.Intellia Therapeutics Presents New Data on Expanded Cell Engineering Capabilities Utilizing Base EditorsNASDAQ:NTLAIntellia Therapeutics Inc
10/03/202123:30GlobeNewswire Inc.Intellia Therapeutics Presents Preclinical Proof of Concept for CRISPR-based In Vivo Editing of Bone Marrow at Keystone eSymp...NASDAQ:NTLAIntellia Therapeutics Inc
06/03/202109:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
06/03/202109:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
06/03/202109:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
06/03/202109:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
02/03/202106:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
26/02/202122:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
25/02/202123:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
25/02/202123:30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
18/02/202123:30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2020 Earnings and Company UpdatesNASDAQ:NTLAIntellia Therapeutics Inc
17/02/202109:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
12/02/202108:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
11/02/202103:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
05/02/202122:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
30/01/202101:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
23/01/202109:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTLAIntellia Therapeutics Inc
23/01/202108:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA